Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: Appropriate interpretation of the guidelines

被引：9

作者：

Antman, EM ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Samuel A Levine Cardiac Unit, Coronary Care Unit, Boston, MA 02115 USA

来源：

AMERICAN HEART JOURNAL | 2003年 / 146卷 / 04期

关键词：

D O I：

10.1016/j.ahj.2003.09.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In 2002, the American College of Cardiology and the American Heart Association published an update to their guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. These revised guidelines make specific recommendations regarding the use of glycoprotein IIb/IIIa inhibitors. This article briefly reviews the evidence supporting the use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-segment elevation myocardial infarction, before moving on to discuss interpretation of these new guidelines.

引用

页数：5

共 11 条

[1] CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism
André, P
Prasad, KSS
Denis, CV
He, M
Papalia, JM
Hynes, RO
Phillips, DR
Wagner, DD
[J]. NATURE MEDICINE, 2002, 8 (03) : 247 - 252
[2] 'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes
Antman, EM
[J]. EUROPEAN HEART JOURNAL, 2002, 23 (18) : 1408 - 1411
[3] Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes -: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention
Boersma, E
Akkerhuis, KM
Théroux, P
Califf, RM
Topol, EJ
Simoons, ML
[J]. CIRCULATION, 1999, 100 (20) : 2045 - 2048
[4] Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials
Boersma, E
Harrington, RA
Moliterno, DJ
White, H
Théroux, P
Van de Werf, F
de Torbal, A
Armstrong, PW
Wallentin, LC
Wilcox, RG
Simes, J
Califf, RM
Topol, EJ
Simoons, ML
[J]. LANCET, 2002, 359 (9302) : 189 - 198
[5] Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban:: Rationale and study design of the international TACTICS-TIMI 18 trial
Cannon, CP
Weintraub, WS
Demopoulos, LA
Robertson, DH
Gormley, GJ
Braunwald, E
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (06) : 731 - 736
[6] *COMM MAN PAT UNST, 2002, J AM COLL CARDIOL, V40, P1366
[7] CD40 signaling in vascular cells:: A key role in atherosclerosis?
Mach, F
Schönbeck, U
Libby, P
[J]. ATHEROSCLEROSIS, 1998, 137 : S89 - S95
[8] Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation
Nannizzi-Alaimo, L
Alves, VL
Phillips, DR
[J]. CIRCULATION, 2003, 107 (08) : 1123 - 1128
[9] Platelet glycoprotein IIb/IIIa inhibitors - Recognition of a two-edged sword?
Quinn, MJ
Plow, EF
Topol, EJ
[J]. CIRCULATION, 2002, 106 (03) : 379 - 385
[10] Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes -: Gradient of benefit related to the revascularization strategy
Roffi, M
Chew, DP
Mukherjee, D
Bhatt, DL
White, JA
Moliterno, DJ
Heeschen, C
Hamm, CW
Robbins, MA
Kleiman, NS
Théroux, P
White, HD
Topol, EJ
[J]. EUROPEAN HEART JOURNAL, 2002, 23 (18) : 1441 - 1448

← 1 2 →